• Karim Amor founded Epineon, a health-focused AI startup launched in 2021.

• Epineon develops metabolic health software and runs a startup incubation program.

• Amor also co-founded NexTraction, which applies AI to streamline startup due diligence.

Moroccan entrepreneur Karim Amor is expanding his footprint in technology and health innovation, applying artificial intelligence (AI) to metabolic health and startup development.

Amor is founder and CEO of Epineon, a company launched in 2021 that builds AI-powered software to support diagnostics, health monitoring and metabolic longevity. The firm integrates multiple fields, including robotics, biomimetics, biotechnology, data analytics and quantum technologies.

Epineon also operates Synergeon CollaboraTech, an incubation program that provides mentorship to early-stage businesses. Its platform uses sensitive metabolic data to design personalized nutrition and fitness plans.

Beyond Epineon, Amor has established a diverse portfolio. He founded JET Group Maroc, which invests in technology, social housing development and organic cosmetics. Since 2020, he has also chaired MeM, a networking hub for Moroccan entrepreneurs.

Most recently, in June 2025, Amor co-founded NexTraction, a venture designed to assist investors and founders in startup validation. The firm’s AI-driven platform automates due diligence by offering real-time market analysis, risk signal detection and predictive scoring.

This article was initially published in French by Melchior Koba
Adapted in English by Ange Jason Quenum